Cargando…
In Vivo Activity of LCB 01-0699, a Prodrug of LCB 01-0648, against Staphylococcus aureus
LCB01-0648 is a novel oxazolidinone compound that shows potent antibacterial activities against most Gram-positive cocci, including the multi-drug resistant Staphylococcus aureus. In this study, in vivo activity of LCB01-0699, a LCB01-0648 prodrug, against S. aureus was evaluated in comparison with...
Autores principales: | Oh, Sang-Hun, Park, Hee-Soo, Lee, Jun-Hyung, Baek, Sung-Yun, Chae, Sang-Eun, Oh, Kyuman, Cho, Young Lag, Kwak, Jin-Hwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149760/ https://www.ncbi.nlm.nih.gov/pubmed/29186032 http://dx.doi.org/10.3390/molecules22122096 |
Ejemplares similares
-
In Vitro Activities of LCB 01-0648, a Novel Oxazolidinone, against Gram-Positive Bacteria
por: Oh, Sang-Hun, et al.
Publicado: (2017) -
Antibacterial Activity of LCB10-0200 against Klebsiella pneumoniae
por: Oh, Sang-Hun, et al.
Publicado: (2021) -
Early Bactericidal Activity of Delpazolid (LCB01-0371) in Patients with Pulmonary Tuberculosis
por: Kim, Ju Sang, et al.
Publicado: (2022) -
Effect of food on the pharmacokinetic characteristics of a single oral dose of LCB01-0371, a novel oxazolidinone antibiotic
por: Sunwoo, Jung, et al.
Publicado: (2018) -
In Vitro Activity of a Novel Siderophore-Cephalosporin LCB10-0200 (GT-1), and LCB10-0200/Avibactam, against Carbapenem-Resistant Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa Strains at a Tertiary Hospital in Korea
por: Nguyen, Le Phuong, et al.
Publicado: (2021)